Adviser charged with insider trading on Pfizer-King deal pleads guilty

Adviser charged with insider trading on Pfizer-King deal pleads guilty


A Long Island, New York, investment adviser accused of engaging in insider trading after being tipped off about Pfizer Inc's $3.6 billion acquisition of King Pharmaceuticals Inc pleaded guilty on Tuesday, federal prosecutors said. Tibor Klein, 43, pleaded guilty to one count of conspiracy to commit securities fraud before U.S. District Judge Joan Azrack in federal court in Brooklyn, New York.



from Biotech News